drugset / Trial / NCT00693784
Treatment of Symptomatic Lumbar Internal Disc Disruption (IDD) With the Biostat® Disc Augmentation System: A Pilot Study
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the safety of the Biostat Disc Augmentation System for the treatment of chronic low-back (lumbar) pain due to symptomatic internal disc disruptions (IDD) and to obtain preliminary efficacy information.
Timeline
- Start
- 2008-06
- Primary completion
- 2009-02
- Completion
- 2011-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Biostat BIOLOGX® Fibrin Sealant | Protein / enzyme biologic | — | Other |
Indications
No indication recorded.